Plain-English translation of NCT06734156 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying the bacteria in your gut to understand how they may relate to colorectal cancer. This study will collect stool samples from people recently diagnosed with colorectal cancer at different points—right after diagnosis, after treatment, and three years later—to see if patterns in gut bacteria can help predict who may be at higher risk, how well treatment works, and how long people survive.
Doctors are discovering that the bacteria living in our gut may play an important role in colorectal cancer development and how people respond to treatment. This study aims to identify these bacterial patterns so they can eventually be used to better predict outcomes and help tailor treatment for colorectal cancer patients in the future.
You likely qualify if…
You likely don't qualify if…
You would provide stool samples at three key times: when you enter the study (right after diagnosis), after you complete your cancer treatment, and again three years after your diagnosis. Researchers will also collect information about your lifestyle, diet, and medical history. The study will track your health and disease status over the three-year period to see how your gut bacteria changes and how it relates to your treatment response and survival.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Portugal